Key result
Among patients admitted for suspected acute coronary syndrome, the 30-day mortality rate was 5.7% overall, including 7.3% for STEMI and 8.4% for NSTEMI.
Observational (n=1,221)
Yes
The CZECH-2 registry demonstrates a high incidence of suspected ACS with a 31% rule-out rate, and highlights that NSTEMI patients have equivalent or worse 30-day mortality compared to STEMI patients due to higher baseline risk.
No takes yet. Share an insight, caveat, or question.
NSTEMI mortality rivals STEMI in suspected ACS admissions; extends registry data but leaves open whether targeted strategies improve outcomes.
Toušek et al. (2014) conducted an observational in suspected acute coronary syndrome (n=1,221). Acute coronary syndrome was evaluated on 30-day mortality. Among patients admitted for suspected acute coronary syndrome, the 30-day mortality rate was 5.7% overall, including 7.3% for STEMI and 8.4% for NSTEMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: